Press Releases
 
Acute Kidney Injury Therapeutics Market Analysis and Research Report by Experts 2026

, 19 February 2019 -- Acute Kidney Injury Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Acute kidney injury can be described as partial or full loss of kidney function because of sudden damage to the organ. Acute kidney injury is different from chronic kidney infection, wherein the kidney function is lost over a period of time. Acute kidney injury is more common among the geriatric population that suffers from various other diseases. The most common cause of the disease is bacterial blood infection. Patients who suffer from acute kidney injury have reduced alkaline phosphatase levels in the body. Less urine discharge, swelling in legs, ankles, and chest pain are some symptoms of acute kidney injury.

Acute kidney injury is increasingly prevalent in both developed and developing countries. Lack of knowledge of proper dosing of non-steroidal anti-inflammatory drugs for pain management across these regions is a major factor that leads to sever acute kidney injury among the geriatric population. According to the Kidney International Journal (2013), nearly 13.3 million people suffer from acute kidney injury across the world; of these over 85% cases were from low and middle income countries.

Obtain Report Details @ https://www.transparencymarketresearch.com/acute-kidney-injury-therapeutics-market.html

Additionally, government initiatives to spread awareness by implementing different programs about the acute kidney is projected boost the global acute kidney injury therapeutics market. However, less awareness in the underdeveloped countries and high cost associated with treatment are likely to hamper the acute kidney injury therapeutics market in the next few years.

Based on test type, the global acute kidney injury therapeutics market can be segmented into urine test, blood test, imaging test, and others. The blood test segment is projected to grow at a rapid pace during the forecast period, as doctors prefer a blood test to check for renal dysfunction in the initial stage of treatment. Doctors observe the rising level of urea and creatinine to measure kidney function. In terms of treatment, the acute kidney injury therapeutics market can be divided into therapy and drugs. The drugs segment is expected to expand at a high CAGR during the forecast period because doctors prefer to first treat acute kidney injury with drugs and drug classes such as recombinant alkaline phosphatase and nephrotoxic agents which are effective for kidney injury.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=51567

In terms of region, the global acute kidney injury therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market. The region is projected to account for significant share of the global acute kidney injury therapeutics market during the forecast period due to increase in incidence of acute kidney injury in the U.S. and favorable health care reimbursement policies. Extensive research and development on drug therapies to treat acute kidney injury by major players in countries such as Germany, Switzerland, and the U.K. is expected to drive the acute kidney injury therapeutics market in Europe.

High prevalence of kidney disorders and increase in the geriatric population are expected to fuel the growth of the acute kidney injury therapeutics market in Asia Pacific during the forecast period. According to the Nature Reviews Nephrology Journal, 1% to 10% hospitalized patients suffered from acute kidney injury in China in 2015. Advancements in tests and diagnosis, increase in per capita income, and availability of drugs are likely to augment the acute kidney injury therapeutics market in Middle East & Africa during the forecast period.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=51567

Key players operating in the global acute kidney injury therapeutics market are Quark Pharmaceuticals, Inc., Alloksys Life Sciences B.V., Angio Biomedica Corporation, Stealth Bio Therapeutics, Inc., Silver Creek Pharmaceuticals, Inc., AM-Pharma Holding, and Ischemix, among others.

# # #


Submitted by hawer on Tuesday, 19 February 2019 at 5:35 PM
Category: Health Care & Medical
 
Related News

Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
Tuesday, 26 Mar 2019

Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
Tuesday, 26 Mar 2019

Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 26 Mar 2019

Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025
Tuesday, 26 Mar 2019

Onchocerciasis Treatment Market Market Growth Opportunities & Technology Developments by 2025
Tuesday, 26 Mar 2019

Related Events

Diagnostic Imaging Update on Kauai
Monday, 25 Mar 2019

8th Drug Formulation and Bioavailability
Monday, 25 Mar 2019

Slow- and Controlled-Release and Stabilized Fertilizers (SCRSFs)
Monday, 25 Mar 2019

3rd Product Complaints Forum
Monday, 25 Mar 2019

14 International Conference on Alzheimer's and Parkinson's Diseases AD/PD™
Tuesday, 26 Mar 2019

Latest News

Electronics at the nanoscale: challenges and opportunities for making metal nanowires
Tuesday, 26 Mar 2019

Hypoparathyroidism Treatment Market Market Report 2016 and Future Opportunity Assessment 2027
Tuesday, 26 Mar 2019

Antidiuretics Market Research Key Players, Industry Overview and Forecasts to 2024
Tuesday, 26 Mar 2019

Vascular Trauma Management Market Market Competitive Landscape Analysis with Forecast by 2025
Tuesday, 26 Mar 2019

Diabetic Retinopathy Market Overview and Regional Outlook Study 2017 - 2025
Tuesday, 26 Mar 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Tuesday, 26 March 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: CCISDA Spring Conference 2019
  • Diagnostic Imaging Update on Kauai
  • Gulf Safety Forum 2019
  • 2nd Pharmacovigilance Audit and Inspection Conference
  • 8th Drug Formulation and Bioavailability

  • Latest Jobs
    Sorry, there are currently no entries posted here.